2008 U.S. Chronic Pain Drug Delivery: Patient Perspective


Regular Price: USD 10,000.00

Special Price USD 7,000.00

30% OFF

* Required Fields

Regular Price: USD 10,000.00

Special Price USD 7,000.00


Be the first to review this product

This study encompasses feedback provided by U.S. patients on aspects of drug delivery and drug treatment for chronic pain, enabling interested stakeholders to gain insight into current and future trends. Data was presented for the general objective point questions as well as analysis by disease subtype where applicable. Patient feedback about awareness, usage, and desired changes was obtained for Voltaren Gel. For device driven delivery, autoinjector technology usage and willingness for adoption is assessed by patients, as well as other vital feedback on the role the device plays in the overall drug product. The corresponding physician deliverable is titled: 2008 U.S. Chronic Pain Drug Delivery - Physician Pers

Table of Contents

2008 U.S. Chronic Pain Drug Delivery, 2008 U.S. Chronic Pain Drug DeliveryPatient PerspectiveResearch Service

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.